This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Expedite Meador's confirmation to FTC, conservative groups tell US lawmakers

( February 25, 2025, 19:52 GMT | Official Statement) -- MLex Summary: Eleven advocacy groups wrote to the US Senate Commerce Committee asking to expedite Mark Meador’s confirmation for the role of Federal Trade Commissioner as he plays an essential role for the agency in tackling the anticompetitive and anti-consumer conduct by Big Tech platforms, pharmaceutical companies and harms caused to young people through anxiety-inducing social media. "We believe Mr. Meador is essential to realizing the President’s goal because of the important role the FTC plays in regulating markets and consumer protection. Indeed, the FTC is one of our premier competition regulators. It evaluates predatory pricing and can bring suit against unlawful cartels that manipulate food prices, our rent, and distortions in the market caused by investors’ DEI and ESG agendas," the letter said.Statement follows. See attached document...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login